Related by context. Frequent words. (Click for all words.) 82 Meets Primary Endpoint 81 Clinical Trial Results 79 Pivotal Phase III 79 Improves Survival 79 Receives Orphan Drug Designation 78 Presents Positive 78 Initiates Phase II 78 Completes Enrollment 78 Drug Candidate 78 Pivotal Phase 78 Patient Enrollment 78 Initiate Phase 78 Pivotal Trial 77 Phase III Clinical Trial 77 Pivotal Study 77 Phase III Trial 75 Preclinical Data 75 Renal Cell Carcinoma 75 Commences Phase 75 II Clinical Trial 74 Drug Shows Promise 74 Significantly Improves 74 Metastatic Melanoma 74 Single Dose 73 refractory chronic lymphocytic 73 Metastatic Colorectal Cancer 73 FDA Accepts 72 Initiates Phase 72 Prostate Cancer Patients 72 Gastric Cancer 72 Chronic Hepatitis C 71 metastatic castration resistant 71 ThermoDox R 71 R bortezomib 71 Phase Ib II 71 Microplasmin 71 Recombinant Human 71 FDA Clears 71 Pirfenidone 71 Well Tolerated 71 Announces FDA Clearance 70 GVAX R 70 R sorafenib tablets 70 J Am Coll 70 Advanced Prostate Cancer 70 Drug Resistant 70 Generic Version 70 Develop Novel 70 Epratuzumab 70 Hepatocellular Carcinoma 70 Chronic Lymphocytic Leukemia 70 J Am Acad 70 Postmenopausal Women 70 Significantly Reduces 70 Monotherapy 70 Study Demonstrates 70 CHEAP ONLINE PHARMACY LOW 70 Benign Prostatic Hyperplasia 70 Tesetaxel 70 Pralatrexate 69 THERAPEUTICS 69 RNAi Therapeutics 69 Receives FDA Clearance 69 Pulmonary Arterial Hypertension 69 Ambrisentan 69 Epidermal Growth Factor Receptor 69 Reduces Risk 69 Monoclonal Antibody 69 Purchase CIALIS Need 69 Cholesterol Drug 69 Patients Treated 69 Dasatinib 69 Golimumab 69 Daclizumab 69 Phase Ib clinical 69 Patients Undergoing 69 Elderly Patients 69 HGS ETR2 69 Inc Therapeutic Competitors 68 Am J Obstet 68 metastatic castrate resistant 68 Voreloxin 68 Alemtuzumab 68 Heart Failure Patients 68 Panzem R 68 Lung Cancer Patients 68 Patent Covering 68 MITTEILUNG UEBERMITTELT VON BUSINESS 68 phase IIb clinical 68 Vandetanib 68 Tumor Growth 68 Acute Myocardial Infarction 68 Myelofibrosis 68 PET FROM 68 Diabetic Neuropathy 68 Low Dose 68 Increases Risk 68 Acute Ischemic Stroke 68 Cyclacel Pharmaceuticals 68 Chronic Heart Failure 68 Diabetic Macular Edema